← 返回

数量与质量:乳腺癌过继性细胞疗法成功的关键

英文原题:Quantity versus quality: Keys to adoptive cell therapy success in breast cancer.

查看英文原题

Quantity versus quality: Keys to adoptive cell therapy success in breast cancer.

PubMed 2022/04/08(内容时间) Med Q1 · IF 13.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

几十年来,关于自体TIL(肿瘤浸润淋巴细胞)在治疗难治性肿瘤中诱导部分甚至完全缓解的报道,推动了对此过程进行优化和改进的方法研究。Zacharias 等 1 报告了一项 II 期研究的结果,该研究在转移性乳腺癌患者中使用新抗原反应性 TIL,观察到两例部分缓解和一例完全缓解。

展开英文摘要原文

Over decades, reports of autologous tumor-infiltrating lymphocytes inducing partial and even complete responses in treatment-refractory tumors has spurred investigation into methods for refining and improving this process. Zacharias et al. 1 report two partial and one complete response from a phase II study utilizing neoantigen-reactive TILs in patients with metastatic breast cancer.

论文信息

作者
Lou E
单位
Masonic Cancer Center and Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: emil-lou@umn.edu.United States
文献类型
评论
期刊
Med (New York, N.Y.)2022 Apr 8
原文标识
PubMed 35590150 · DOI 10.1016/j.medj.2022.03.007